2nd Annual Conference on Genetics

Paris, France

Join Europe’s leading Genetics Conference

Saturday 20 February 2021

Paris, France + Online

Session Topics

  • Gene Therapy
  • CRISPR
  • Biomarkers
  • Hereditary Diseases
  • Genetic Testing
  • Ethical Issues in Genetics

Call for Science

Speaking at the 2nd Annual Conference on Genetics allows you to reach a greater audience and share your knowledge on a global scale. Submit an abstract or case report using the button below.

Global recognition for your work

High visibility & impact

Presentation Types

Keynote presentation

30-40 minutes

Session presentation

25-30 minutes

Poster presentation

5-15 Minutes

Important Deadlines

  • Abstracts/Full-Text Paper Submission Deadline: January 20, 2021
  • Final Registration Deadline: February 1, 2021
  • Conference Date: February 20, 2021

This page is down for maintenance until October 20. Check back later to view the updated interactive scientific program.

Featured Keynote Speakers

Terrence Murphy

Yale School of Medicine

Integration of Fall Prevention into State Policy in Connecticut

Dr. Murphy is a member of the biostatistics staff of the Program on Aging. With twelve years experience in the design and manufacture of clinical instrumentation and advanced training in engineering statistics, he is interested in the application of engineering tools to research on aging. Current areas of investigation include multivariate statistics for characterization of multiple co–morbidity, robust design techniques for assessing the tradeoffs of multiple medication use, and the use of hierarchical models, propensity scores, and Bayesian techniques to enhance the analysis of non-randomized interventional designs such as the fall–related utilization of healthcare services by older persons in the state of Connecticut.

Helen Noble

Queen’s University Belfast

Mindfulness Based Interventions for people for kidney disease

Dr Helen Noble’s research is focused on two areas; (i) improving the quality of life of people with end-stage kidney disease (and their carers) from diagnosis through to end of life. 

Joan-Lluis Vives-Corrons

University of Barcelona

Diagnostic approach of hereditary red blood cell membranopathies: From Osmotic Gradient Ektacytometry (OGE) to Next Generation Sequencing (NGS)

Joan-Lluis Vives Corrons is a Professor of Medicine (1976-present) and Head of the Red Blood Cell Pathology Unit (1997 –present) at the Hospital Clínic i Provincial (University of Barcelona), with main activity focused on the diagnosis of RBC defects and in the identification of low prevalence anaemias or “Rare Anaemias”.Research has mainly based on physiopathology, molecular mechanisms and epidemiology of red blood cell (RBC) disorders due to hereditary enzymopathies (G6PD, PK and others), haemoglobinopathies (Sickle-cell anaemia and thalassaemias) and membrane defects.

Jan Ilhan Kizilhan

Institute for Transcultural Health Science, Germany

Transcultural Aspects of Psychotraumatology in Medicine

Jan Ilhan Kizilhan is a psychologist, author and publisher, with research interests in psychotraumatology, sexual violation, trauma, terror and war, transcultural psychiatry, psychotherapy, clinical psychology and psychotherapy, migration research and socialization-war research.

Andrea Kleindienst

Dept. of Neurosurgery Univ. Erlangen-Nürnberg

Therapeutic Enhancement of Adult Neurogenesis following Brain Injury

Dr. Andrea Kleindienst was born and raised in Berlin, where she studied medicine at the Free University Berlin and earned her doctorate. She is a German board-certified neurosurgeon since 1998 and has an accreditation by the United States Educational Commission for Foreign Medical Graduates in 2003. Dr. Kleindienst completed graduation in X-Ray and computed tomography diagnostics, emergency and intensive care medicine, manual medicine/ chiropractic therapy, acupuncture, and psychosomatic medicine. 

Jan Verbruggen

Maastricht University Medical Center

Pre-operative cardiac evaluation of patients with a hip fracture, still sensible?

Dr. Verbruggen studied medicine at the Catholic University of Leuven. After obtaining his medical degree, he was trained as a surgeon in the University Hospitals of the University of Leuven and the hospitals affiliated with it. In 1993 he was recognized as a General Surgeon, after which he further specialized in trauma surgery at the Klinikum in Garmisch-Partenkirchen, Germany and subsequently at the Maastricht UMC + (then Academic Hospital Maastricht). He worked for a year as Oberarzt at the Unfall Surgery department of the Klinikum in Aachen and returned to Maastricht UMC + in 1999 as a staff member for Surgery with a focus on Trauma Surgery.

Thomas F. Lüscher

Royal Brompton & Harefield Hospitals/Imperial College

Inflammation and Acute Coronary Syndromes

Professor Thomas F. Lüscher is the Director of Research, Education & Development and Consultant of Cardiology at Royal Brompton & Harefield Hospital Trust and Imperial College in London and Director of the Center for Molecular Cardiology at the University Zurich (Campus Schlieren).

From 1996 – 2017 he was Chairman of Cardiology at the University Hospital Zurich and Director of the Center for Molecular Cardiology at the University Zurich (Campus Schlieren, Wagi-Areal), Switzerland.

Jolien Gooijers

KU Leuven, Belgium

Advanced neuroimaging in relation to motor control post traumatic brain injury

Step 1


Step 2

Payment

Basic

$ 369
  • Access to all sessions

Basic + Membership

$ 899
  • 1 Year ESMED membership
  • Access to all sessions

VIP

$ 1,099
  • Full-text publication *
  • 2 Year ESMED membership
  • Presentation preparation assistance
  • Access to all sessions

* Publication of one manuscript in the Medical Research Archives, the official open-access journal of the European Society of Medicine.